BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 406106)

  • 1. A radioactive substrate and assay for alpha-L-iduronidase.
    Di Natale P; Leder IG; Neufeld EF
    Clin Chim Acta; 1977 Jun; 77(3):211-8. PubMed ID: 406106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. alpha-L-iduronidase, beta-D-glucuronidase, and 2-sulfo-L-iduronate 2-sulfatase: preparation and characterization of radioactive substrates from heparin.
    Hopwood JJ
    Carbohydr Res; 1979 Mar; 69():203-16. PubMed ID: 106967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substrates for the assay of alpha-L-iduronidase.
    Thompson JN
    Clin Chim Acta; 1978 Nov; 89(3):435-46. PubMed ID: 709885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective depolymerisation of dermatan sulfate: production of radiolabelled substrates for alpha-L-iduronidase, sulfoiduronate sulfatase, and beta-D-glucuronidase.
    Hopwood JJ; Muller VJ
    Carbohydr Res; 1983 Oct; 122(2):227-39. PubMed ID: 6423280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A fluorometric assay using 4-methylumbelliferyl alpha-L-iduronide for the estimation of alpha-L-iduronidase activity and the detection of Hurler and Scheie syndromes.
    Hopwood JJ; Muller V; Smithson A; Baggett N
    Clin Chim Acta; 1979 Mar; 92(2):257-65. PubMed ID: 114339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properties of alpha-L-iduronidase in cultured skin fibroblasts from alpha-L-iduronidase-deficient patients.
    Fujibayashi S; Minami R; Ishikawa Y; Wagatsuma K; Nakao T; Tsugawa S
    Hum Genet; 1984; 65(3):268-72. PubMed ID: 6421718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. alpha-L-Iduronidase deficiency in mucopolysaccharidosis type I against a radiolabelled sulfated disaccharide substrate derived from dermatan sulfate.
    Muller VJ; Hopwood JJ
    Clin Genet; 1984 Nov; 26(5):414-21. PubMed ID: 6437709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human alpha-L-iduronidase. 2. Catalytic properties.
    Clements PR; Muller V; Hopwood JJ
    Eur J Biochem; 1985 Oct; 152(1):29-34. PubMed ID: 4043083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the substrate 4-methylumbelliferyl-alpha-l-iduronide with phenyl-alpha-L-iduronide for the diagnosis of Hurler's disease in cultured cells.
    Butterworth J; Broadhead DM
    J Inherit Metab Dis; 1980; 2(3):71-4. PubMed ID: 6796763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microtest for determination of alpha-L-iduronidase in plasma and leucocytes and its potential for diagnosing alpha-L-iduronidase deficiency.
    Den Tandt WR; Scharpe S; Giesberts M; Poorthuis BJ
    Lancet; 1984 Apr; 1(8380):794. PubMed ID: 6143109
    [No Abstract]   [Full Text] [Related]  

  • 11. Fluorometric measurement of alpha-L-iduronidase activity using 4-methylumbelliferyl-alpha-L-iduronide.
    Minami R; Watanabe Y; Kudoh T; Oyanagi K; Nakao T
    Tohoku J Exp Med; 1980 Apr; 130(4):381-4. PubMed ID: 6781103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of alpha-L-iduronidase activity in various tissues from two sibs affected with presumably the Hurler-Scheie compound syndrome.
    Thompson JN; Finley SC; Lorincz AE; Finley WH
    Birth Defects Orig Artic Ser; 1975; 11(6):341-6. PubMed ID: 811284
    [No Abstract]   [Full Text] [Related]  

  • 13. Biochemical discrimination of Hurler and Scheie syndromes.
    Hopwood JJ; Muller V
    Clin Sci (Lond); 1979 Sep; 57(3):265-72. PubMed ID: 38945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic enzymology of alpha-L-iduronidase with special reference to a sulphated disaccharide derived from heparin.
    Hopwood JJ; Muller V
    Clin Sci (Lond); 1982 Feb; 62(2):193-201. PubMed ID: 6895615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiolabelled oligosaccharides as substrates for the estimation of sulfamidase and the detection of the Sanfilippo type A syndrome.
    Hopwood JJ; Elliott H
    Clin Chim Acta; 1981 Apr; 112(1):55-66. PubMed ID: 6786803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human alpha-L-iduronidase. II. Comparative biochemical and immunologic properties of the purified low and high uptake forms.
    Schuchman EH; Guzman NA; Takada G; Desnick RJ
    Enzyme; 1984; 31(3):166-75. PubMed ID: 6734578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucopolysaccharidosis type I subtypes. Presence of immunologically cross-reactive material and in vitro enhancement of the residual alpha-L-iduronidase activities.
    Schuchman EH; Desnick RJ
    J Clin Invest; 1988 Jan; 81(1):98-105. PubMed ID: 3121676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Alpha-L-iduronidase activity in fibroblasts of patients with Hurler syndrome].
    Stareprawo G; Grimm U; Machill G; Knapp A; Wehnert M
    Acta Biol Med Ger; 1975; 34(6):1079-82. PubMed ID: 812313
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnosis of the mucopolysaccharidoses using cultured skin fibroblasts and amniotic fluid cells.
    Butterworth J
    J Inherit Metab Dis; 1978; 1(1):25-8. PubMed ID: 117232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct demonstration of binding of a lysosomal enzyme, alpha-L-iduronidase, to receptors on cultured fibroblasts.
    Rome LH; Weissmann B; Neufeld EF
    Proc Natl Acad Sci U S A; 1979 May; 76(5):2331-4. PubMed ID: 287076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.